newsfilter
← Latest News
GlobeNewswire·

Replimune to Report the Fiscal Second Quarter 2027 Financial Results and Provide Corporate Update on October 28, 2026

  • Replimune Group, Inc. (NASDAQ: REPL) will host a conference call on Wednesday, October 28, 2026, at 8:00 a.m. ET to discuss Q2 2026 financial results & provide a corporate update.
  • The fiscal second quarter ended September 30, 2026.
  • Listeners can register for the webcast via a provided link, while analysts can use a separate link for the Q&A session.
  • A replay of the webcast will be available on the company's investor website approximately two hours after the call concludes.
  • Participants are advised to join 15 minutes prior to the scheduled start time.
  • Replimune, founded in 2015 & headquartered in Woburn, MA, develops novel oncolytic immunotherapies using its proprietary RPx platform based on an HSV-1 backbone.
  • The RPx platform aims to induce direct tumor killing & systemic anti-tumor immune responses, with product candidates expected to be synergistic with other cancer treatments.
  • Investor inquiries should be directed to Chris Brinzey of ICR Healthcare.
  • Media inquiries should be directed to Arleen Goldenberg of Replimune.